-
Symbol
-
MREO on Nasdaq
-
Investment type
-
Equity / American Depositary Shares, each representing five ordinary shares, nominal value of (pound)0.003 per share
-
Latest Disclosed Ownership
-
39M shares
-
Security Ownership
-
4.9%
Shares, Excluding Options vs Price
Value, Excluding Options
Mangrove Partners IM, LLC ownership in Mereo BioPharma Group plc American Depositary Shares, each representing five ordinary shares, nominal value of (pound)0.003 per share (MREO)
2025-11-14 - Mangrove Partners IM, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 39M shares of Mereo BioPharma Group plc American Depositary Shares, each representing five ordinary shares, nominal value of (pound)0.003 per share (MREO).
This represents 4.9% percent ownership of the company.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.